MICRO MN DIN 00786942
Status: Marketed
Holder: SANDOZ CANADA INCORPORATED
Health Canada record
| Active ingredient(s) | MANGANESE (MANGANESE SULFATE) 0.1 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Intravenous |
|---|
| Schedule | ETHICAL |
|---|
| Class | Human |
|---|
| ATC | A12CX OTHER MINERAL PRODUCTS |
|---|
| Original market date | 31-Dec-1992 |
|---|
| Current status date | 29-Jul-2006 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MANGANESE (MANGANESE SULFATE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02218569 | BALANCE ACE - CAP | PHARMAVITE LLC | Capsule | MANGANESE (MANGANESE SULFATE) 1.5 MG; SELENIUM (SODIUM SELENATE) 15 MCG; BETA-CAROTENE 10000 UNIT; ASCORBIC ACID 250 MG; DL-ALPHA TOCOPHERYL ACETATE 200 UNIT; ZINC (ZINC OXIDE) 7.5 MG; COPPER (CUPRIC OXIDE) 1 MG | Cancelled Post Market |
| 02238580 | FORMULA ANT-CEL | ABUNDANCE NATURALLY LTD | Tablet | MANGANESE (MANGANESE SULFATE) 2.5 MG; CHROMIUM (CHROMIUM HVP CHELATE) 50 MCG | Cancelled Pre Market |
| 00786950 | MICRO MN | SANDOZ CANADA INCORPORATED | Solution | MANGANESE (MANGANESE SULFATE) 0.5 MG | Cancelled Post Market |
| 02244938 | PREMIUM PRENATAL | QUEST VITAMINS A DIV OF PURITY LIFE HEALTH PRODUCTS | Tablet | MANGANESE (MANGANESE SULFATE) 5 MG; COPPER (CUPRIC SULFATE) 2 MG; IODINE (POTASSIUM IODIDE) 0.15 MG; SELENIUM (SELENIUM HVP CHELATE) 35 MCG; CHROMIUM (CHROMIUM HVP CHELATE) 25 MCG; MOLYBDENUM (MOLYBDENUM HVP CHELATE) 25 MCG; VANADIUM (VANADIUM HVP CHELATE) 25 MCG; BETA-CAROTENE (PROVITAMIN A) 1500 UNIT; VITAMIN A (RETINOL PALMITATE) 2500 UNIT; VITAMIN D3 400 UNIT; VITAMIN E (D-ALPHA TOCOPHERYL ACETATE) 30 UNIT; ASCORBIC ACID 100 MG; VITAMIN B1 (THIAMINE HYDROCHLORIDE) 3 MG; VITAMIN B2 5 MG; NICOTINAMIDE 20 MG; D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) 15 MG; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 15 MG; FOLIC ACID 1 MG; BIOTIN 35 MCG; VITAMIN B12 15 MCG; CALCIUM (CALCIUM CARBONATE) 250 MG; MAGNESIUM (MAGNESIUM OXIDE) 125 MG; ZINC (ZINC SULFATE) 25 MG; IRON (FERROUS FUMARATE) 30 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 27428 | 2022-01-20 | Supplement to a New Drug Submission (SNDS) | Safety Updates to the Product Monograph (PM) in response to
an Advisement Letter, and converting the PM to the 2020
Master Template |
| 8179 | 2006-07-28 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
Request a quote for MICRO MN
How to read a Canadian DIN record